CT4-47021-31316
3 vaccinations
6 coded responses
36 check-ins
6 free-text entries
4 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 207 / MD
- Registered
- 2022-06-24
- Relationship
- Child or adolescent in my care
- Guardian
- UJ8-21181-15863
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-24
Registered in v-safe
-
2022-06-24
Dose 1 — Pfizer-BioNTech
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-01
-
2022-07-08
Survey response — day 14, dose 1, under 3MedDRA: Productive cough, Rhinorrhoea — Feeling: GoodFree text: Wet cough with runny nose, for about a week, but it was relatively mild.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-15
Dose 2 — Pfizer-BioNTech
- 2022-07-15
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-21
- 2022-07-22
-
2022-07-29
Survey response — day 14, dose 2, under 3MedDRA: Erythema, Pyrexia, SARS-CoV-2 test negative, Viral infection — Feeling: GoodFree text: He had a random virus that caused a low grade fever for about 12 hours and tiny red dots on his chest and back for about 48 hours. He tested negative on a covid home test and symptoms resolved quickly.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-05
-
2022-08-12
Survey response — day 28, dose 2, under 3MedDRA: Cough, Respiratory distress, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Runny nose, moderate respiratory distress, cough.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-12
Report sent to call center — day 28, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-08-15
-
2022-08-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-19
- 2022-08-26
-
2022-09-16
Dose 3 — Pfizer-BioNTech
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
-
2022-09-30
Survey response — day 14, dose 3, under 3MedDRA: Ear infection, Tympanic membrane perforation — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Ear infection that resulted in a burst eardrum.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — day 14, dose 3, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-03
-
2022-10-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-07
- 2022-10-14
-
2022-10-21
Survey response — day 35, dose 3, under 3MedDRA: Cough, Ear infection, Eye pruritus, Lacrimation increased, Upper-airway cough syndrome — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Itchy, watery eyes, ear infection, post nasal drip, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Report sent to call center — day 35, dose 3, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-28
-
2022-12-16
Survey response — 3 months, dose 3, under 3MedDRA: Hand-foot-and-mouth disease, Nasopharyngitis, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Colds, RSV, and Hand Foot Mouth disease.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Report sent to call center — 3 months, dose 3, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Pfizer-BioNTech | No |
| 2 | 2022-07-15 | Pfizer-BioNTech | No |
| 3 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 successful
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Wet cough with runny nose, for about a week, but it was relatively mild.
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: He had a random virus that caused a low grade fever for about 12 hours and tiny red dots on his chest and back for about 48 hours. He tested negative on a covid home test and symptoms resolved quickly.
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Runny nose, moderate respiratory distress, cough.
Release 12 (Under 3) — day 14, dose 3, under 3
Symptoms: Ear infection that resulted in a burst eardrum.
Release 12 (Under 3) — day 35, dose 3, under 3
Symptoms: Itchy, watery eyes, ear infection, post nasal drip, cough
Release 12 (Under 3) — 3 months, dose 3, under 3
Symptoms: Colds, RSV, and Hand Foot Mouth disease.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Erythema | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory distress | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Tympanic membrane perforation | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release